Oncology News | pharmaphorum

News

ADC specialist Solve raises $120m, and other biofinancings

Our round-up of biofinancings is led by a $120m round for ADC specialist Solve, with Aspen, Artios, Profluent, and Gate Bioscience also raising funds.

News

Gloved hand punches a karate pad held up

GSK unit and AnaptysBio trade lawsuits over Jemperli

A spat between GSK/Tesaro and AnaptysBio over cancer drug Jemperli has escalated into litigation, with both parties claiming breach of contract.

News

NICE backs five AI tools for bowel cancer screening

Five AI technologies used during a colonoscopy exam to help detect the early signs of bowel cancer have been backed for use by the NHS in England.

News

Black and white image of a bearded man putting his forearm over his eyes

Advocate slams muted response to UK male health strategy

A mental health campaigner has condemned the "stunning silence" from mainstream media in the UK as the first-ever men's health strategy is revealed.

News

Bayer takes on Boehringer with FDA nod for lung cancer drug

Bayer joins Boehringer with FDA approval for a second-line, oral therapy for HER2-positive lung cancer, setting up a marketing battle in the US.

News

Bayer gets EU approval for menopause drug Lynkuet

Bayer now has approval on both sides of the Atlantic for Lynkuet, with the EU backing it for symptoms caused by both menopause and breast cancer.

ADC specialist Solve raises $120m, and other biofinancings

GSK unit and AnaptysBio trade lawsuits over Jemperli

NICE backs five AI tools for bowel cancer screening

Advocate slams muted response to UK male health strategy

Bayer takes on Boehringer with FDA nod for lung cancer drug

Bayer gets EU approval for menopause drug Lynkuet

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks